Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production

Abstract

The enzyme carnitine palmitoyltransferase-1 (CPT1) regulates long-chain fatty acid (LCFA) entry into mitochondria, where the LCFAs undergo β-oxidation. To investigate the mechanism(s) by which central metabolism of lipids can modulate energy balance, we selectively reduced lipid oxidation in the hypothalamus. We decreased the activity of CPT1 by administering to rats a ribozyme-containing plasmid designed specifically to decrease the expression of this enzyme or by infusing pharmacological inhibitors of its activity into the third cerebral ventricle. Either genetic or biochemical inhibition of hypothalamic CPT1 activity was sufficient to substantially diminish food intake and endogenous glucose production. These results indicated that changes in the rate of lipid oxidation in selective hypothalamic neurons signaled nutrient availability to the hypothalamus, which in turn modulated the exogenous and endogenous inputs of nutrients into the circulation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Inhibition of hypothalamic CPT1.
Figure 2: Genetic or pharmacological inhibition of CPT1 in ARC reduced CPT1 activity and increased LCFA-CoA.
Figure 3: Inhibition of hypothalamic CPT1L by genetic or pharmacological means decreased food intake.
Figure 4: Inhibition of hypothalamic CPT1 improved hepatic but not peripheral insulin action.

Similar content being viewed by others

Accession codes

Accessions

GenBank/EMBL/DDBJ

References

  1. Hill, J.O. & Peters, J.C. Environmental contributions to obesity epidemic. Science 280, 1371–1374 (1998).

    Article  CAS  Google Scholar 

  2. Kopelman, P.G. & Hitman, G.A. Diabetes. Exploding type II. Lancet 352 (suppl. 4), SIV5 (1998).

  3. Woods, S.C., Lotter, E.C., McKay, D.L. & Porte, D., Jr. Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons. Nature. 282, 503–505 (1979).

    Article  CAS  Google Scholar 

  4. Bruning, J.C. et al. Role of brain insulin receptor in control of body weight and reproduction. Science 289, 2122–2125 (2000).

    Article  CAS  Google Scholar 

  5. Friedman, J.M. Obesity in the new millennium. Nature 404, 632–634 (2000).

    Article  CAS  Google Scholar 

  6. Air, E.L. et al. Small molecule insulin mimetics reduce food intake and body weight and prevent development of obesity. Nat. Med. 8, 179–183 (2002).

    Article  CAS  Google Scholar 

  7. Schwartz, M.W., Woods, S.C., Porte, D. Jr., Seeley, R.J. & Baskin, D.G. Central nervous system control of food intake. Nature 404, 661–671 (2000).

    Article  CAS  Google Scholar 

  8. Ahima, R.S. et al. Role of leptin in the neuroendocrine response to fasting. Nature 382, 250–252 (1996).

    Article  CAS  Google Scholar 

  9. Wang, J., Liu, R., Hawkins, M., Barzilai, N. & Rossetti, L. A nutrient-sensing pathway regulates leptin gene expression in muscle and fat. Nature 393, 684–688 (1998).

    Article  CAS  Google Scholar 

  10. Loftus, T.M. et al. Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. Science 288, 2379–2381 (2000).

    Article  CAS  Google Scholar 

  11. Obici, S. et al. Central administration of oleic acid inhibits glucose production and food intake. Diabetes 51, 271–275 (2002).

    Article  CAS  Google Scholar 

  12. Makimura, H. et al. Cerulenin mimics effects of leptin on metabolic rate, food intake, and body weight independent of the melanocortin system, but unlike leptin, cerulenin fails to block neuroendocrine effects of fasting. Diabetes 50, 733–739 (2001).

    Article  CAS  Google Scholar 

  13. Shimokawa, T., Kumar, M.V. & Lane, M.D. Effect of a fatty acid synthase inhibitor on food intake and expression of hypothalamic neuropeptides. Proc. Natl. Acad. Sci. USA 99, 66–71 (2002).

    Article  CAS  Google Scholar 

  14. McGarry, G.D., Mannaert, G.P. & Foster, D.W. A possible role for malonyl-CoA in the regulation of hepatic fatty acid oxidation and ketogenesis. J. Clin. Invest. 60, 265–270 (1977).

    Article  CAS  Google Scholar 

  15. Zammit, V.A. Regulation of ketone body metabolism. A cellular perspective. Diabetes Rev. 2, 132–155 (1994).

    Google Scholar 

  16. Obici, S. et al. Central melanocortin receptors regulate insulin action. J. Clin. Invest. 108, 1079–1085 (2001).

    Article  CAS  Google Scholar 

  17. Liu, L. et al. Intracerebroventricular (ICV) leptin regulates hepatic but not peripheral glucose fluxes. J. Biol. Chem. 273, 31160–31167 (1998).

    Article  CAS  Google Scholar 

  18. Miller, J.C., Gnaedinger, J.M. & Rapaport, S.I. Utilization of plasma fatty acid in rat brain: distribution of [14C]palmitate between oxidative and synthetic pathways. J. Neurochem. 49, 1507–1514 (1987).

    Article  CAS  Google Scholar 

  19. Goto M. & Spitzer J.J. Fatty acids profiles of various lipids in the cerebrospinal fluid. Proc. Exp. Biol. Med. 136, 1294–1296 (1971).

    Article  CAS  Google Scholar 

  20. Briscoe, C.P. et al. The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids. J. Biol. Chem. 278, 11303–11311 (2003).

    Article  CAS  Google Scholar 

  21. Lunzer, M.A., Manning, J.A. & Ockner, R.K. Inhibition of rat liver acetyl coenzyme A carboxylase by long chain acyl coenzyme A and fatty acid. J. Biol. Chem. 252, 5483–5487 (1977).

    CAS  PubMed  Google Scholar 

  22. Brun, T., Assimacopoulos-Jeannet, F., Corkey, B.E. & Prentki, M. Long-chain fatty acids inhibit acetyl-CoA carboxylase gene expression in the pancreatic beta-cell line INS-1. Diabetes 46, 393–400 (1997).

    Article  CAS  Google Scholar 

  23. Blazquez, C., Sanchez, C., Daza, A., Galve-Roperh, I. & Guzman, M. The stimulation of ketogenesis by cannabinoids in cultured astrocytes defines carnitine palmitoyltransferase I as a new ceramide-activated enzyme. J. Neurochem. 72, 1759–1768 (1999).

    Article  CAS  Google Scholar 

  24. Di Marzo, V. et al. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 410, 822–825 (2001).

    Article  CAS  Google Scholar 

  25. Esser, V., Britton, C.H., Weis, B.C., Foster, D.W. & McGarry, J.D. Cloning, sequencing, and expression of a cDNA encoding rat liver carnitine palmitoyltransferase I. Direct evidence that a single polypeptide is involved in inhibitor interaction and catalytic function. J. Biol. Chem. 268, 5817–5822 (1993).

    CAS  PubMed  Google Scholar 

  26. Birikh, K.R., Heaton, P.A. & Eckstein, F. The structure, function and application of the hammerhead ribozyme. Eur. J. Biochem. 245, 1–16 (1997).

    Article  CAS  Google Scholar 

  27. Boussif, O. et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. USA 92, 7297–7301 (1995).

    Article  CAS  Google Scholar 

  28. Goula, D. et al. Size, diffusibility and transfection performance of linear PEI/DNA complexes in the mouse central nervous system. Gene Ther. 5, 712–717 (1998).

    Article  CAS  Google Scholar 

  29. Palkovits M. Isolated removal of hypothalamic or other brain nuclei of the rat. Brain Res. 59, 449–450 (1973).

    Article  CAS  Google Scholar 

  30. Obici, S., Feng, Z., Karkanias, G., Baskin, D.G. & Rossetti, L. Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats. Nat. Neurosci. 5, 566–572 (2002).

    Article  CAS  Google Scholar 

  31. Paxinos, G. & Watson, C. The Rat Brain in Stereotaxic Coordinates 3rd edn. (Academic Press, 1997).

    Google Scholar 

  32. Arduini, A. et al. Evidence for the involvement of carnitine-dependent long-chain acyltransferases in neuronal triglyceride and phospholipid fatty acid turnover. J. Neurochem. 62, 1530–1538 (1994).

    Article  CAS  Google Scholar 

  33. Woldegiorgis, G., Spennetta, T., Corkey, B.E., Williamson, J.R. & Shrago, E. Extraction of tissue long-chain acyl-CoA esters and measurement by reverse-phase high-performance liquid chromatography. Anal. Biochem. 150, 8–12 (1985).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by grants from the National Institutes of Health (to L.R.; DK48321 and DK45024) and from the Albert Einstein College of Medicine Diabetes Research & Training Center. S.O. was the recipient of a post-doctoral fellowship and a Junior Faculty Award from the American Diabetes Association.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Luciano Rossetti.

Ethics declarations

Competing interests

A.A. and R.C. are employed by a drug company and they may have interest in the development of ST1326 as a potential treatment for diabetes or obesity.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Obici, S., Feng, Z., Arduini, A. et al. Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production. Nat Med 9, 756–761 (2003). https://doi.org/10.1038/nm873

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm873

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing